Exact Mass: 339.1082

Exact Mass Matches: 339.1082

Found 150 metabolites which its exact mass value is equals to given mass value 339.1082, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Topiramate

[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5,3-d]pyran-3a-yl]methyl sulfamate

C12H21NO8S (339.0988)


Topiramate is an anticonvulsant drug used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved, and now most frequently prescribed for, the prevention of migraines. It has been used by psychiatrists to treat bipolar disorder, although it is not FDA approved for this purpose and such use is somewhat controversial. This drug has been investigated for use in treatment of obesity, especially to aid in the reduction of binge eating, and also as a possible treatment for alcoholism. However, these uses are not actively promoted by the manufacturer, and like its use for bipolar disorder, are off-label uses. The drug is also used in clinical trials to treat Post Traumatic Stress Disorder. A pilot study suggests that Topiramate is possibly effective against infantile spasm; Chemically, topiramate is a sulfamate-substituted monosaccharide, related to fructose, a rather unusual chemical structure for an anticonvulsant. Topiramate is quickly absorbed after oral use. Most of the drug (70\\\%) is excreted in the urine as unchanged drug. The remainder is extensively metabolized by hydroxylation, hydrolysis, and glucuronidation. Six metabolites have been identified in humans, none of which constitutes more than 5\\\% of an administered dose. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. There is evidence that topiramate has a specific effect on GluR5 kainate receptors. It is also an inhibitor of carbonic anhydrase, particularly subtypes II and IV, but this action is weak and unlikely to be related to its anticonvulsant actions, but may account for the bad taste and the development of renal stones seen during treatment. Its possible effect as a mood stabilizer seems to occur before anticonvulsant qualities at lower dosages. Topiramate inhibits maximal electroshock and pentylenetetrazol-induced seizures as well as partial and secondarily generalized tonic-clonic seizures in the kindling model, findings predictive of a broad spectrum of antiseizure activities clinically; Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. It has been used by psychiatrists to treat bipolar disorder, although it is not FDA approved for this purpose and such use is somewhat controversial. This drug has been investigated for use in treatment of obesity, especially to aid in the reduction of binge eating, and also as a possible treatment for alcoholism. However, these uses are not actively promoted by the manufacturer, and like its use for bipolar disorder, are off-label uses. The drug is also used in clinical trials to treat Post Traumatic Stress Disorder. A pilot study suggests that Topiramate is possibly effective against infantile spasm. In May 2006 the U.S. National Institutes of Health web site clinicaltrials.gov listed several studies sponsored by Ortho-McNeil which propose to examine the use of topiramate on migraine, cluster, and severe headaches within various demographics; Topiramate (brand name: Topamax) is an anticonvulsant drug produced by Ortho-McNeil, a division of Johnson & Topiramate (brand name: Topamax) is an anticonvulsant drug produced by Ortho-McNeil, a division of Johnson & Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the preventio... CONFIDENCE standard compound; INTERNAL_ID 395; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3585; ORIGINAL_PRECURSOR_SCAN_NO 3584 CONFIDENCE standard compound; INTERNAL_ID 395; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3597; ORIGINAL_PRECURSOR_SCAN_NO 3596 CONFIDENCE standard compound; INTERNAL_ID 395; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3586; ORIGINAL_PRECURSOR_SCAN_NO 3584 CONFIDENCE standard compound; INTERNAL_ID 395; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3591; ORIGINAL_PRECURSOR_SCAN_NO 3588 CONFIDENCE standard compound; INTERNAL_ID 395; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3659; ORIGINAL_PRECURSOR_SCAN_NO 3657 CONFIDENCE standard compound; INTERNAL_ID 395; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3594; ORIGINAL_PRECURSOR_SCAN_NO 3593 C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D007004 - Hypoglycemic Agents Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase[1][2][3].

   

Vulgaxanthin I

(4Z)-4-[(2E)-2-{[1-carboxy-3-(C-hydroxycarbonimidoyl)propyl]imino}ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylate

C14H17N3O7 (339.1066)


Vulgaxanthin I is found in common beet. Vulgaxanthin I is a yellow pigment from Beta species Vulgaxanthin I is a food colouran Yellow pigment from Beta subspecies Food colourant. Vulgaxanthin I is found in red beetroot, common beet, and root vegetables. D004396 - Coloring Agents > D050858 - Betalains

   

Phenoxybenzamine HCl

Phenoxybenzamine hydrochloride

C18H23Cl2NO (339.1157)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Phenoxybenzamine hydrochloride is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine hydrochloride also shows antitumor activity[1][2].

   

Moguisteine

Moguisteine

C16H21NO5S (339.114)


C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent

   

N-(1-Deoxy-b-D-fructopyranosyl) (R)C(S)S-alliin

3-(Prop-2-ene-1-sulphinyl)-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}propanoic acid

C12H21NO8S (339.0988)


N-(1-Deoxy-b-D-fructopyranosyl) (R)C(S)S-alliin is found in onion-family vegetables. N-(1-Deoxy-b-D-fructopyranosyl) (R)C(S)S-alliin is isolated from garlic (Allium sativum). Isolated from garlic (Allium sativum) [DFC]. N-(1-Deoxy-b-D-fructopyranosyl) (R)C(S)S-alliin is found in garlic and onion-family vegetables.

   

1-Hydroxyrutacridone epoxide

1,5-dihydroxy-11-methyl-2-(2-methyloxiran-2-yl)-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1107)


1-Hydroxyrutacridone epoxide is an alkaloid from the callus tissue of Ruta graveolens (rue). Alkaloid from the callus tissue of Ruta graveolens (rue).

   

Rutagravine

6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1(12),2(9),10,14,16,18-hexaen-13-one

C19H17NO5 (339.1107)


Rutagravine is found in herbs and spices. Rutagravine is an alkaloid from the callus tissue of Ruta graveolens (rue). Alkaloid from the callus tissue of Ruta graveolens (rue). Rutagravine is found in herbs and spices.

   

20-Hydroxyrutacridone epoxide

5-hydroxy-2-[2-(hydroxymethyl)oxiran-2-yl]-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1107)


20-Hydroxyrutacridone epoxide is found in herbs and spices. 20-Hydroxyrutacridone epoxide is an alkaloid from the roots and callus tissue cultures of Ruta graveolens (rue). Alkaloid from the roots and callus tissue cultures of Ruta graveolens (rue). 20-Hydroxyrutacridone epoxide is found in herbs and spices.

   

n2-(1-Carboxyethyl)-2'-deoxyguanosine

2-({6-hydroxy-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,9-dihydro-2H-purin-2-ylidene}amino)propanoate

C13H17N5O6 (339.1179)


   

Loxoribine

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-1H-purine-6,8-dione

C13H17N5O6 (339.1179)


   

Moguisteine

Ethyl 3-{2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl}-3-oxopropanoic acid

C16H21NO5S (339.114)


   

glutamine-betaxanthin

(2S)-4-[(2Z)-2-{[(1S)-1-carboxy-3-(C-hydroxycarbonimidoyl)propyl]imino}ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylate

C14H17N3O7 (339.1066)


D004396 - Coloring Agents > D050858 - Betalains

   

Norisocorydione

Norisocorydione

C19H17NO5 (339.1107)


   
   

Aristoyagonine

Aristoyagonine

C19H17NO5 (339.1107)


   

Norchelidonine

Norchelidonine

C19H17NO5 (339.1107)


   

8-Oxotetrahydrothalifendine

8-Oxotetrahydrothalifendine

C19H17NO5 (339.1107)


   
   

Norimeluteine

Norimeluteine

C19H17NO5 (339.1107)


   

12-Hydroxycrychine

(-)-12-Hydroxycrychine

C19H17NO5 (339.1107)


   

Demethylsonodione

Demethylsonodione

C19H17NO5 (339.1107)


   
   
   

(-)-13-beta-Hydroxystylopine

(-)-13-beta-Hydroxystylopine

C19H17NO5 (339.1107)


   
   

O=C(OC)CCCN1C(=O)c2c(-c3c1cccc3)cc1OCOc1c2

O=C(OC)CCCN1C(=O)c2c(-c3c1cccc3)cc1OCOc1c2

C19H17NO5 (339.1107)


   
   

(14R)-Reframidine N-oxide

(14R)-Reframidine N-oxide

C19H17NO5 (339.1107)


   
   

Maybridge3_000499

Maybridge3_000499

C18H17N3O2S (339.1041)


   
   

SCHEMBL16266743

SCHEMBL16266743

C19H17NO5 (339.1107)


   

SCHEMBL7911722

SCHEMBL7911722

C16H21NO5S (339.114)


   
   

SCHEMBL14640411

SCHEMBL14640411

C19H17NO5 (339.1107)


   

(+)-N-formylhernangerine

(+)-N-formylhernangerine

C19H17NO5 (339.1107)


   
   
   

aristololactam CIII

aristololactam CIII

C19H17NO5 (339.1107)


   

5-hydroxynoracronycine alcohol

5-hydroxynoracronycine alcohol

C19H17NO5 (339.1107)


   

Aristolactam C III

Aristolactam C III

C19H17NO5 (339.1107)


   

desulfo-5-methylsulfanylpentyl GL|desulfoglucoberteroin|DS-GBE

desulfo-5-methylsulfanylpentyl GL|desulfoglucoberteroin|DS-GBE

C13H25NO5S2 (339.1174)


   

(+)-11-methoxynornoelistine

(+)-11-methoxynornoelistine

C19H17NO5 (339.1107)


   

N-Ethoxycarbonylethylcrinasiadine

N-Ethoxycarbonylethylcrinasiadine

C19H17NO5 (339.1107)


   

5,6-dihydro-3,10-dihydroxy-9,11-dimethoxy-8H-dibenzo[a,g]quinolizine-8-one|pendulamine B

5,6-dihydro-3,10-dihydroxy-9,11-dimethoxy-8H-dibenzo[a,g]quinolizine-8-one|pendulamine B

C19H17NO5 (339.1107)


   

2-(7-Methoxy-1,3-benzodioxol-5-yl)-8-methoxy-1-methylquinolin-4(1H)-one

2-(7-Methoxy-1,3-benzodioxol-5-yl)-8-methoxy-1-methylquinolin-4(1H)-one

C19H17NO5 (339.1107)


   

Citracridone III

Citracridone III

C19H17NO5 (339.1107)


   

3-(1,1-Dimethoxy-2-oxoethoxy)-9,10-dihydro-1-methoxy-9-oxo-4-acridinecarboxaldehyde

3-(1,1-Dimethoxy-2-oxoethoxy)-9,10-dihydro-1-methoxy-9-oxo-4-acridinecarboxaldehyde

C19H17NO5 (339.1107)


   

Topiramate

Topiramate

C12H21NO8S (339.0988)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D007004 - Hypoglycemic Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3635 Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase[1][2][3].

   

glutamine-betaxanthin

glutamine-betaxanthin

C14H17N3O7 (339.1066)


   
   

N-Fructosyl alliin

N-Fructosyl alliin

C12H21NO8S (339.0988)


Annotation level-3

   

N2-S-Carboxyethyl-deoxyguanosine

N2-S-Carboxyethyl-deoxyguanosine

C13H17N5O6 (339.1179)


   

Asn-Val-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-methylpentanoic acid

C14H17N3O7 (339.1066)


   

Val-Asn-OH

(S)-5-amino-2-(3-isopropoxy-4-nitrobenzamido)-5-oxopentanoic acid

C14H17N3O7 (339.1066)


   

Rutagravine

6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.0^{2,9}.0^{3,7}.0^{14,19}]icosa-1,9,11,14,16,18-hexaen-13-one

C19H17NO5 (339.1107)


   

1-Hydroxyrutacridone epoxide

1,5-dihydroxy-11-methyl-2-(2-methyloxiran-2-yl)-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1107)


   

20-Hydroxyrutacridone epoxide

5-hydroxy-2-[2-(hydroxymethyl)oxiran-2-yl]-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO5 (339.1107)


   

N-(1-Deoxy-b-D-fructopyranosyl) (R)C(S)S-alliin

3-(prop-2-ene-1-sulfinyl)-2-{[(2,3,4,5-tetrahydroxyoxan-2-yl)methyl]amino}propanoic acid

C12H21NO8S (339.0988)


   

Mofezolac

Mofezolac

C19H17NO5 (339.1107)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

1-phenyl-7-pyridin-3-yl-5-(trifluoromethyl)benzimidazole

1-phenyl-7-pyridin-3-yl-5-(trifluoromethyl)benzimidazole

C19H12F3N3 (339.0983)


   

1-benzyl-3-methyl 6-methoxyindole-1,3-dicarboxylate

1-benzyl-3-methyl 6-methoxyindole-1,3-dicarboxylate

C19H17NO5 (339.1107)


   

4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinazolin-7-ol

4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinazolin-7-ol

C18H14FN3O3 (339.1019)


   

(S)-N-DESISOPROPYLPROPRANOLOL

(S)-N-DESISOPROPYLPROPRANOLOL

C19H17NO5 (339.1107)


   

Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate

Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate

C18H17N3O2S (339.1041)


   

6-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANEHYDRAZIDE 2,2,2-TRIFLUOROACETATE

6-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANEHYDRAZIDE 2,2,2-TRIFLUOROACETATE

C12H16F3N3O5 (339.1042)


   

2-Bromo-5-nitro-6-picoline

2-Bromo-5-nitro-6-picoline

C14H24Cl3N3 (339.1036)


   

Pim1/AKK1-IN-1

Pim1/AKK1-IN-1

C20H13N5O (339.112)


   

SC-10

5-chloro-N-heptylnaphthalene-1-sulfonamide

C17H22ClNO2S (339.106)


   

Cyprazepam

7-chloro-N-(cyclopropylmethyl)-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine

C19H18ClN3O (339.1138)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

3-(3-(4-(2-METHOXYETHOXY)PHENYL)ISOXAZOL-5-YL)BENZOIC ACID

3-(3-(4-(2-METHOXYETHOXY)PHENYL)ISOXAZOL-5-YL)BENZOIC ACID

C19H17NO5 (339.1107)


   

(R)-3-((BENZYLOXY)AMINO)-4-(2,4,5-TRIFLUOROPHENYL)BUTANOIC ACID

(R)-3-((BENZYLOXY)AMINO)-4-(2,4,5-TRIFLUOROPHENYL)BUTANOIC ACID

C17H16F3NO3 (339.1082)


   

Loxoribine

Loxoribine

C13H17N5O6 (339.1179)


C308 - Immunotherapeutic Agent > C210 - Immunoadjuvant > C2554 - Vaccine Adjuvant C2140 - Adjuvant Loxoribine (7-Allyl-8-oxoguanosine) is a guanosine analog with anti-viral and anti-tumor activities. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist[1][2][3].

   

2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran

2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran

C19H17NO5 (339.1107)


   

2-[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPOXY]-BENZOIC ACID METHYL ESTER

2-[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPOXY]-BENZOIC ACID METHYL ESTER

C19H17NO5 (339.1107)


   

Benthiavalicarb

Benthiavalicarb

C15H18FN3O3S (339.1053)


D016573 - Agrochemicals D010575 - Pesticides

   

2-Amino-6-[4-(6-chloropyridin-2-yl)piperazin-1-yl]pyridine-3,5-dicarbonitrile

2-Amino-6-[4-(6-chloropyridin-2-yl)piperazin-1-yl]pyridine-3,5-dicarbonitrile

C16H14ClN7 (339.0999)


   

1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethoxyindole-2,3-dione

1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethoxyindole-2,3-dione

C19H17NO5 (339.1107)


   

n2-(1-Carboxyethyl)-2-deoxyguanosine

n2-(1-Carboxyethyl)-2-deoxyguanosine

C13H17N5O6 (339.1179)


   

3-[[2-(6-Methoxy-3-benzofuranyl)-1-oxoethyl]amino]benzoic acid methyl ester

3-[[2-(6-Methoxy-3-benzofuranyl)-1-oxoethyl]amino]benzoic acid methyl ester

C19H17NO5 (339.1107)


   

3-[[(3-Methoxyphenyl)-oxomethyl]amino]-2-benzofurancarboxylic acid ethyl ester

3-[[(3-Methoxyphenyl)-oxomethyl]amino]-2-benzofurancarboxylic acid ethyl ester

C19H17NO5 (339.1107)


   

N(2)-(S)-carboxyethyl-2-deoxyguanosine

N(2)-(S)-carboxyethyl-2-deoxyguanosine

C13H17N5O6 (339.1179)


   

N(2)-(R)-carboxyethyl-2-deoxyguanosine

N(2)-(R)-carboxyethyl-2-deoxyguanosine

C13H17N5O6 (339.1179)


   

Topiramate-13C6

Topiramate-13C6

C12H21NO8S (339.0988)


   

(2r,3r,4r,5r)-4,5-Dihydroxy-2-(Hydroxymethyl)-6-Oxopiperidin-3-Yl Beta-D-Glucopyranoside

(2r,3r,4r,5r)-4,5-Dihydroxy-2-(Hydroxymethyl)-6-Oxopiperidin-3-Yl Beta-D-Glucopyranoside

C12H21NO10 (339.1165)


   

S-benzyl-gamma-glutamylcysteine

S-benzyl-gamma-glutamylcysteine

C15H19N2O5S- (339.1015)


   

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-7-prop-2-enyl-3H-purine-6,8-dione

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-7-prop-2-enyl-3H-purine-6,8-dione

C13H17N5O6 (339.1179)


   
   

2-[[9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]amino]propanoic acid

2-[[9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]amino]propanoic acid

C13H17N5O6 (339.1179)


   

N-(4-chlorophenyl)-5-methyl-2-[(4-methylphenyl)methyl]-3-pyrazolecarboxamide

N-(4-chlorophenyl)-5-methyl-2-[(4-methylphenyl)methyl]-3-pyrazolecarboxamide

C19H18ClN3O (339.1138)


   

3-(Dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl ester

3-(Dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl ester

C19H17NO5 (339.1107)


   

2-[[4-(2,4-Dimethylphenyl)-5-(3-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

2-[[4-(2,4-Dimethylphenyl)-5-(3-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

C17H17N5OS (339.1154)


   

N-(4-fluorophenyl)-2-(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)-2-oxoacetamide

N-(4-fluorophenyl)-2-(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)-2-oxoacetamide

C18H14FN3O3 (339.1019)


   

N-(5-methyl-7-phenyl-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-thiophenecarboxamide

N-(5-methyl-7-phenyl-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-thiophenecarboxamide

C17H17N5OS (339.1154)


   

1-(3-Chloro-4-fluorophenyl)-4-[(4-methyl-1-piperazinyl)-oxomethyl]-2-pyrrolidinone

1-(3-Chloro-4-fluorophenyl)-4-[(4-methyl-1-piperazinyl)-oxomethyl]-2-pyrrolidinone

C16H19ClFN3O2 (339.115)


   

3-(Phenoxymethyl)-2-benzofurancarboxylic acid (1-amino-1-oxopropan-2-yl) ester

3-(Phenoxymethyl)-2-benzofurancarboxylic acid (1-amino-1-oxopropan-2-yl) ester

C19H17NO5 (339.1107)


   

N-(3,4-dimethylphenyl)-2-[(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)thio]acetamide

N-(3,4-dimethylphenyl)-2-[(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)thio]acetamide

C17H17N5OS (339.1154)


   

2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide

2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide

C16H19ClFN3O2 (339.115)


   

1-[(1S,2S)-2-[(3-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]triazole

1-[(1S,2S)-2-[(3-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]triazole

C19H18ClN3O (339.1138)


   

Vulgaxanthin-I

Vulgaxanthin-I

C14H17N3O7 (339.1066)


D004396 - Coloring Agents > D050858 - Betalains

   

3,10-dihydroxy-2,4-dimethoxy-7,8-dihydro-6-azatetraphen-5-one

3,10-dihydroxy-2,4-dimethoxy-7,8-dihydro-6-azatetraphen-5-one

C19H17NO5 (339.1107)


   

(1r,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

(1r,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

C19H17NO5 (339.1107)


   

(1r,24r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaen-24-ol

(1r,24r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaen-24-ol

C19H17NO5 (339.1107)


   

17-hydroxy-16-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-14-one

17-hydroxy-16-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-14-one

C19H17NO5 (339.1107)


   

6,7,11-trihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

6,7,11-trihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO5 (339.1107)


   

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-1-ol

C19H17NO5 (339.1107)


   

4,5,16-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.0³,⁸.0¹³,¹⁷]heptadeca-1(16),3,5,7,9,13(17),14-heptaen-12-one

4,5,16-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.0³,⁸.0¹³,¹⁷]heptadeca-1(16),3,5,7,9,13(17),14-heptaen-12-one

C19H17NO5 (339.1107)


   

4-(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

4-(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C14H17N3O7 (339.1066)


   

6,7,8,14-tetramethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1,3,5,7,9(16),10(15),11,13-octaen-13-ol

6,7,8,14-tetramethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1,3,5,7,9(16),10(15),11,13-octaen-13-ol

C19H17NO5 (339.1107)


   

(?)-12-hydroxycrychine

NA

C19H17NO5 (339.1107)


{"Ingredient_id": "HBIN000876","Ingredient_name": "(?)-12-hydroxycrychine","Alias": "NA","Ingredient_formula": "C19H17NO5","Ingredient_Smile": "CN1C2CC3=CC4=C(C=C3C1(CC5=CC6=C(C=C25)OCO6)O)OCO4","Ingredient_weight": "339.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9946","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101148425","DrugBank_id": "NA"}

   

(—)-8-oxotetrahydrothalifendine

NA

C19H17NO5 (339.1107)


{"Ingredient_id": "HBIN013874","Ingredient_name": "(\u2014)-8-oxotetrahydrothalifendine","Alias": "NA","Ingredient_formula": "C19H17NO5","Ingredient_Smile": "COC1=C(C=CC2=C1C(=O)N3CCC4=CC5=C(C=C4C3C2)OCO5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38245","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

aristolactam c ii; 9-methoxy

NA

C19H17NO5 (339.1107)


{"Ingredient_id": "HBIN016770","Ingredient_name": "aristolactam c ii; 9-methoxy","Alias": "NA","Ingredient_formula": "C19H17NO5","Ingredient_Smile": "NA","Ingredient_weight": "339.34","OB_score": "NA","CAS_id": "106283-32-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6674","PubChem_id": "NA","DrugBank_id": "NA"}

   

6-{2h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2,3-dimethoxyphenol

6-{2h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl}-2,3-dimethoxyphenol

C19H17NO5 (339.1107)


   

(2r)-8-hydroxy-10,15-dimethoxy-4-methyl-5-azapentacyclo[10.5.0.0²,⁵.0⁴,⁶.0⁶,¹¹]heptadeca-1(17),7,10,12,14-pentaene-9,16-dione

(2r)-8-hydroxy-10,15-dimethoxy-4-methyl-5-azapentacyclo[10.5.0.0²,⁵.0⁴,⁶.0⁶,¹¹]heptadeca-1(17),7,10,12,14-pentaene-9,16-dione

C19H17NO5 (339.1107)


   

(2s,4e)-4-[(2z)-2-{[(1r)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4e)-4-[(2z)-2-{[(1r)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C14H17N3O7 (339.1066)


   

(1s)-17-hydroxy-16-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-14-one

(1s)-17-hydroxy-16-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-14-one

C19H17NO5 (339.1107)


   

(1r,12r,13s)-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(1r,12r,13s)-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C19H17NO5 (339.1107)


   

(1s,12s,13r)-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

(1s,12s,13r)-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C19H17NO5 (339.1107)


   

5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol

C19H17NO5 (339.1107)


   

(12s)-17-methoxy-4,6,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0³,⁷.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3(7),8,16,18(22)-hexaene

(12s)-17-methoxy-4,6,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0³,⁷.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3(7),8,16,18(22)-hexaene

C19H17NO5 (339.1107)


   

17-methoxy-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

17-methoxy-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C19H17NO5 (339.1107)


   

(13r)-7-methoxy-13-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,11,14,16,18-heptaene-13,16-diol

(13r)-7-methoxy-13-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,11,14,16,18-heptaene-13,16-diol

C19H17NO5 (339.1107)


   

4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),4,8,13(17),14-hexaene-3,6-dione

4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),4,8,13(17),14-hexaene-3,6-dione

C19H17NO5 (339.1107)


   

6,7-dimethoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]icosa-1(20),3,5,7,13,15(19)-hexaen-9-one

6,7-dimethoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]icosa-1(20),3,5,7,13,15(19)-hexaen-9-one

C19H17NO5 (339.1107)


   

8-methoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-methylquinolin-4-one

8-methoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-methylquinolin-4-one

C19H17NO5 (339.1107)


   

(4e)-4-(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(4e)-4-(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C14H17N3O7 (339.1066)


   

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaen-24-ol

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaen-24-ol

C19H17NO5 (339.1107)


   

(2r)-6,7-dimethoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]icosa-1(20),3,5,7,13,15(19)-hexaen-9-one

(2r)-6,7-dimethoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]icosa-1(20),3,5,7,13,15(19)-hexaen-9-one

C19H17NO5 (339.1107)


   

16-hydroxy-4,15-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),4,8,13(17),14-hexaene-3,6-dione

16-hydroxy-4,15-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),4,8,13(17),14-hexaene-3,6-dione

C19H17NO5 (339.1107)


   

6,8,14,15-tetramethoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaen-11-ol

6,8,14,15-tetramethoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaen-11-ol

C19H17NO5 (339.1107)


   

(12s)-17-methoxy-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

(12s)-17-methoxy-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C19H17NO5 (339.1107)


   

(12s)-17-hydroxy-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene-11-carbaldehyde

(12s)-17-hydroxy-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene-11-carbaldehyde

C19H17NO5 (339.1107)


   

methyl 7-[3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-2-imino-1h-pyrrolo[2,3-d]pyrimidine-5-carboxylate

methyl 7-[3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-2-imino-1h-pyrrolo[2,3-d]pyrimidine-5-carboxylate

C13H17N5O6 (339.1179)


   

ethyl 3-{6-oxo-9h-[1,3]dioxolo[4,5-j]phenanthridin-5-yl}propanoate

ethyl 3-{6-oxo-9h-[1,3]dioxolo[4,5-j]phenanthridin-5-yl}propanoate

C19H17NO5 (339.1107)


   

3-methanesulfinyl-n-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

3-methanesulfinyl-n-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO8S (339.0988)


   

(1s)-16-hydroxy-17-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaen-14-one

(1s)-16-hydroxy-17-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaen-14-one

C19H17NO5 (339.1107)


   

(2s)-6,11-dihydroxy-2-(hydroxymethyl)-2,5-dimethyl-1-oxa-5-azatetraphen-10-one

(2s)-6,11-dihydroxy-2-(hydroxymethyl)-2,5-dimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO5 (339.1107)


   

(4z)-4-(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(4z)-4-(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C14H17N3O7 (339.1066)


   

(2s,4z)-4-[(2e)-2-{[(1r)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4z)-4-[(2e)-2-{[(1r)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C14H17N3O7 (339.1066)


   

6,11-dihydroxy-2-(hydroxymethyl)-2,5-dimethyl-1-oxa-5-azatetraphen-10-one

6,11-dihydroxy-2-(hydroxymethyl)-2,5-dimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO5 (339.1107)


   

(2e)-3-methanesulfinyl-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2e)-3-methanesulfinyl-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO8S (339.0988)


   

3-(2h-1,3-benzodioxol-5-yl)-n-[2-(2h-1,3-benzodioxol-5-yl)ethyl]prop-2-enimidic acid

3-(2h-1,3-benzodioxol-5-yl)-n-[2-(2h-1,3-benzodioxol-5-yl)ethyl]prop-2-enimidic acid

C19H17NO5 (339.1107)


   

(12r)-17-methoxy-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

(12r)-17-methoxy-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C19H17NO5 (339.1107)


   

3,11-dihydroxy-2,10-dimethoxy-7,8-dihydro-6-azatetraphen-5-one

3,11-dihydroxy-2,10-dimethoxy-7,8-dihydro-6-azatetraphen-5-one

C19H17NO5 (339.1107)


   

methyl 4-{6-oxo-9h-[1,3]dioxolo[4,5-j]phenanthridin-5-yl}butanoate

methyl 4-{6-oxo-9h-[1,3]dioxolo[4,5-j]phenanthridin-5-yl}butanoate

C19H17NO5 (339.1107)


   

(2e)-3-[(r)-methanesulfinyl]-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2e)-3-[(r)-methanesulfinyl]-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO8S (339.0988)


   

6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

6,11-dihydroxy-6,20-dimethyl-4,8-dioxa-20-azapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1,9,11,14,16,18-hexaen-13-one

C19H17NO5 (339.1107)


   

4,5-dimethoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]icosa-1(20),3,5,7,13,15(19)-hexaen-9-one

4,5-dimethoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]icosa-1(20),3,5,7,13,15(19)-hexaen-9-one

C19H17NO5 (339.1107)


   

(2e)-3-[(s)-methanesulfinyl]-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2e)-3-[(s)-methanesulfinyl]-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO8S (339.0988)


   

(2e)-3-(2h-1,3-benzodioxol-5-yl)-n-[2-(2h-1,3-benzodioxol-5-yl)ethyl]prop-2-enimidic acid

(2e)-3-(2h-1,3-benzodioxol-5-yl)-n-[2-(2h-1,3-benzodioxol-5-yl)ethyl]prop-2-enimidic acid

C19H17NO5 (339.1107)